Skip to content

Acute Phase Reactant in Non-COVID-19 Bacterial Pneumonia

Acute Phase Reactant in Non-COVID-19 Community Acquired Pneumonia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05926089
Enrollment
51
Registered
2023-07-03
Start date
2020-10-01
Completion date
2021-05-30
Last updated
2023-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute-Phase Reaction, Pneumonia

Brief summary

This study is a cross-sectional study, was conducted at Chest department of Kasr Al-ainy Hospital, Cairo university during the period between October 2020 and April 2021. The aim of the work was to evaluate levels of acute phase reactants(APR) in Non-COVID-19 bacterial pneumonia, and to correlate between levels of APR and the disease severity.

Detailed description

51 patients were included in our study, diagnosed as Non-COVID pneumonia Inclusion criteria: 1. PCR(polymerase chain reaction) negative for COVID. 2. All patients of both sexes with pneumonia . Exclusion criteria: 1. Non pulmonary infections. 2. Post surgery patients. 3. Renal patients. 4. hepatic patients. 5. Cardiac patients. 6. Recent pulmonary embolism. Methodology in details: All patients were subjected to: 1. Full history with emphasis on: * Epidemiological features (age, gender). * Risk factors (smoking, DM). * Clinical presentation (cough, Fever and duration of illness). 2. Clinical examination (local chest examination). 3. Laboratory investigations: venous blood samples were taken to measure APR

Interventions

DIAGNOSTIC_TESTBlood sampling

blood sampling to measure APR

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* COVID-19 negative bacterial pneumonia

Exclusion criteria

* COVID-19 positive * other non-pulmonary infections

Design outcomes

Primary

MeasureTime frameDescription
measurement of APR levels in non-Covid-19 pneumonia6 monthsassessment of the level of APR and its relation to disease severity

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026